0 XP   0   0   0

Kwality Pharmaceuticals Ltd
Buy, Hold or Sell?

Should you buy, hold or sell Kwality Pharmaceuticals Ltd?

I guess you are interested in Kwality Pharmaceuticals Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Kwality Pharmaceuticals Ltd

Let's start. I'm going to help you getting a better view of Kwality Pharmaceuticals Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Kwality Pharmaceuticals Ltd even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Kwality Pharmaceuticals Ltd is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Kwality Pharmaceuticals Ltd. The closing price on 2023-02-07 was INR345.45 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Kwality Pharmaceuticals Ltd Daily Candlestick Chart
Kwality Pharmaceuticals Ltd Daily Candlestick Chart
Summary









1. Valuation of Kwality Pharmaceuticals Ltd




Current price per share

INR345.45

2. Growth of Kwality Pharmaceuticals Ltd




Is Kwality Pharmaceuticals Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$21.6m$19m$2.6m12.0%

How much money is Kwality Pharmaceuticals Ltd making?

Current yearPrevious yearGrowGrow %
Making money$3.1m$3.6m-$497.6k-15.7%
Net Profit Margin4.2%6.7%--

How much money comes from the company's main activities?

3. Financial Health of Kwality Pharmaceuticals Ltd




Comparing to competitors in the industry




  Industry Rankings ()  



Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

1.1. Profitability of Kwality Pharmaceuticals Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Kwality Pharmaceuticals Ltd earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Kwality Pharmaceuticals Ltd to the  industry mean.
  • A Net Profit Margin of 4.2% means that ₹0.04 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Kwality Pharmaceuticals Ltd:

  • The MRQ is 4.2%. The company is making a profit. +1
  • The TTM is 4.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ4.2%TTM4.2%0.0%
TTM4.2%YOY6.7%-2.5%
TTM4.2%5Y4.7%-0.5%
5Y4.7%10Y4.9%-0.2%
1.1.2. Return on Assets

Shows how efficient Kwality Pharmaceuticals Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Kwality Pharmaceuticals Ltd to the  industry mean.
  • 6.2% Return on Assets means that Kwality Pharmaceuticals Ltd generated ₹0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Kwality Pharmaceuticals Ltd:

  • The MRQ is 6.2%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 6.2%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ6.2%TTM6.2%0.0%
TTM6.2%YOY8.1%-1.8%
TTM6.2%5Y5.7%+0.5%
5Y5.7%10Y6.0%-0.3%
1.1.3. Return on Equity

Shows how efficient Kwality Pharmaceuticals Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Kwality Pharmaceuticals Ltd to the  industry mean.
  • 14.6% Return on Equity means Kwality Pharmaceuticals Ltd generated ₹0.15 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Kwality Pharmaceuticals Ltd:

  • The MRQ is 14.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 14.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.6%TTM14.6%0.0%
TTM14.6%YOY19.2%-4.6%
TTM14.6%5Y13.1%+1.5%
5Y13.1%10Y13.9%-0.7%

1.2. Operating Efficiency of Kwality Pharmaceuticals Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Kwality Pharmaceuticals Ltd is operating .

  • Measures how much profit Kwality Pharmaceuticals Ltd makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Kwality Pharmaceuticals Ltd to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Kwality Pharmaceuticals Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y2.3%-2.3%
5Y2.3%10Y2.5%-0.2%
1.2.2. Operating Ratio

Measures how efficient Kwality Pharmaceuticals Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.16 means that the operating costs are ₹1.16 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Kwality Pharmaceuticals Ltd:

  • The MRQ is 1.162. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.162. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.162TTM1.1620.000
TTM1.162YOY1.178-0.015
TTM1.1625Y1.047+0.115
5Y1.04710Y0.966+0.082

1.3. Liquidity of Kwality Pharmaceuticals Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Kwality Pharmaceuticals Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.29 means the company has ₹1.29 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Kwality Pharmaceuticals Ltd:

  • The MRQ is 1.294. The company is just able to pay all its short-term debts.
  • The TTM is 1.294. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.294TTM1.2940.000
TTM1.294YOY1.315-0.021
TTM1.2945Y1.274+0.020
5Y1.27410Y1.2750.000
1.3.2. Quick Ratio

Measures if Kwality Pharmaceuticals Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Kwality Pharmaceuticals Ltd to the  industry mean.
  • A Quick Ratio of 0.44 means the company can pay off ₹0.44 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Kwality Pharmaceuticals Ltd:

  • The MRQ is 0.442. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.442. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.442TTM0.4420.000
TTM0.442YOY0.432+0.010
TTM0.4425Y0.669-0.227
5Y0.66910Y0.698-0.028

1.4. Solvency of Kwality Pharmaceuticals Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Kwality Pharmaceuticals Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Kwality Pharmaceuticals Ltd to industry mean.
  • A Debt to Asset Ratio of 0.57 means that Kwality Pharmaceuticals Ltd assets are financed with 57.4% credit (debt) and the remaining percentage (100% - 57.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Kwality Pharmaceuticals Ltd:

  • The MRQ is 0.574. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.574. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.574TTM0.5740.000
TTM0.574YOY0.582-0.008
TTM0.5745Y0.555+0.019
5Y0.55510Y0.558-0.003
1.4.2. Debt to Equity Ratio

Measures if Kwality Pharmaceuticals Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Kwality Pharmaceuticals Ltd to the  industry mean.
  • A Debt to Equity ratio of 134.8% means that company has ₹1.35 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Kwality Pharmaceuticals Ltd:

  • The MRQ is 1.348. The company is able to pay all its debts with equity. +1
  • The TTM is 1.348. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.348TTM1.3480.000
TTM1.348YOY1.391-0.043
TTM1.3485Y1.255+0.093
5Y1.25510Y1.269-0.014

2. Market Valuation of Kwality Pharmaceuticals Ltd

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Kwality Pharmaceuticals Ltd generates.

  • Above 15 is considered overpriced but always compare Kwality Pharmaceuticals Ltd to the  industry mean.
  • A PE ratio of 75.08 means the investor is paying ₹75.08 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Kwality Pharmaceuticals Ltd:

  • The EOD is 28.306. Very good. +2
  • The MRQ is 75.077. Neutral. Compare to industry.
  • The TTM is 75.077. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD28.306MRQ75.077-46.771
MRQ75.077TTM75.0770.000
TTM75.077YOY3.906+71.170
TTM75.0775Y21.917+53.159
5Y21.91710Y25.097-3.180
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Kwality Pharmaceuticals Ltd.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Kwality Pharmaceuticals Ltd:

  • The MRQ is 86.853. Seems overpriced? -1
  • The TTM is 86.853. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ86.853TTM86.8530.000
TTM86.853YOY2.218+84.636
TTM86.8535Y28.567+58.286
5Y28.56710Y28.5670.000

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Kwality Pharmaceuticals Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 10.99 means the investor is paying ₹10.99 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Kwality Pharmaceuticals Ltd:

  • The EOD is 4.143. Neutral. Compare to industry.
  • The MRQ is 10.988. Seems overpriced? -1
  • The TTM is 10.988. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD4.143MRQ10.988-6.845
MRQ10.988TTM10.9880.000
TTM10.988YOY0.752+10.236
TTM10.9885Y2.628+8.361
5Y2.62810Y2.469+0.159
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Kwality Pharmaceuticals Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--10.03910.0390%-50.562+604%8.245+22%13.897-28%
Book Value Growth--1.1371.1370%1.225-7%1.171-3%1.171-3%
Book Value Per Share--83.38483.3840%73.345+14%90.292-8%82.269+1%
Book Value Per Share Growth--1.1371.1370%0.592+92%1.281-11%1.281-11%
Current Ratio--1.2941.2940%1.315-2%1.274+2%1.275+2%
Debt To Asset Ratio--0.5740.5740%0.582-1%0.555+3%0.558+3%
Debt To Equity Ratio--1.3481.3480%1.391-3%1.255+7%1.269+6%
Dividend Per Share--1.8671.8670%0.400+367%1.892-1%1.603+16%
Dividend Per Share Growth--4.6674.6670%0.134+3392%3.169+47%3.169+47%
Eps--12.20412.2040%14.119-14%8.746+40%7.576+61%
Eps Growth--0.8640.8640%1.761-51%1.239-30%1.239-30%
Free Cash Flow Per Share--4.3374.3370%1.540+182%-1.948+145%-1.836+142%
Free Cash Flow Per Share Growth--2.8162.8160%2.109+34%-0.280+110%-0.280+110%
Free Cash Flow To Equity Per Share--7.1807.1800%20.777-65%-5.170+172%-4.129+158%
Free Cash Flow To Equity Per Share Growth--0.3460.3460%2.393-86%-43.474+12681%-43.474+12681%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--104.935--------
Intrinsic Value_10Y_min--87.926--------
Intrinsic Value_1Y_max--5.681--------
Intrinsic Value_1Y_min--5.521--------
Intrinsic Value_3Y_max--20.754--------
Intrinsic Value_3Y_min--19.535--------
Intrinsic Value_5Y_max--40.269--------
Intrinsic Value_5Y_min--36.673--------
Net Profit Margin--0.0420.0420%0.067-38%0.047-10%0.049-14%
Operating Margin----0%-0%0.023-100%0.025-100%
Operating Ratio--1.1621.1620%1.178-1%1.047+11%0.966+20%
Pb Ratio4.143-165%10.98810.9880%0.752+1361%2.628+318%2.469+345%
Pe Ratio28.306-165%75.07775.0770%3.906+1822%21.917+243%25.097+199%
Peg Ratio--86.85386.8530%2.218+3817%28.567+204%28.567+204%
Price Per Share345.450-165%916.250916.2500%55.150+1561%210.990+334%187.583+388%
Price To Total Gains Ratio29.015-165%76.95876.9580%-1.099+101%22.185+247%18.082+326%
Profit Growth--0.8640.8640%6.148-86%1.887-54%1.887-54%
Quick Ratio--0.4420.4420%0.432+2%0.669-34%0.698-37%
Return On Assets--0.0620.0620%0.081-23%0.057+9%0.060+3%
Return On Equity--0.1460.1460%0.192-24%0.131+11%0.139+5%
Revenue Growth--1.3841.3840%1.435-4%1.220+13%1.220+13%
Total Gains Per Share--11.90611.9060%-50.162+521%10.137+17%15.500-23%
Total Gains Per Share Growth--2.2372.2370%-10.550+572%0.366+511%0.366+511%
Usd Book Value--21658745.90021658745.9000%19052877.800+14%16852299.200+29%15705449.100+38%
Usd Book Value Change Per Share--0.1210.1210%-0.612+604%0.100+22%0.168-28%
Usd Book Value Per Share--1.0091.0090%0.887+14%1.093-8%0.995+1%
Usd Dividend Per Share--0.0230.0230%0.005+367%0.023-1%0.019+16%
Usd Eps--0.1480.1480%0.171-14%0.106+40%0.092+61%
Usd Free Cash Flow--1126425.3001126425.3000%400013.900+182%-5897.540+101%-4914.617+100%
Usd Free Cash Flow Per Share--0.0520.0520%0.019+182%-0.024+145%-0.022+142%
Usd Free Cash Flow To Equity Per Share--0.0870.0870%0.251-65%-0.063+172%-0.050+158%
Usd Price Per Share4.180-165%11.08711.0870%0.667+1561%2.553+334%2.270+388%
Usd Profit--3170018.5003170018.5000%3667618.900-14%2264207.660+40%2178512.233+46%
Usd Revenue--75633881.40075633881.4000%54648887.700+38%48105500.520+57%44965745.733+68%
Usd Total Gains Per Share--0.1440.1440%-0.607+521%0.123+17%0.188-23%
 EOD+3 -2MRQTTM+0 -0YOY+23 -185Y+24 -1810Y+24 -18

3.2. Fundamental Score

Let's check the fundamental score of Kwality Pharmaceuticals Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1528.306
Price to Book Ratio (EOD)Between0-14.143
Net Profit Margin (MRQ)Greater than00.042
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.442
Current Ratio (MRQ)Greater than11.294
Debt to Asset Ratio (MRQ)Less than10.574
Debt to Equity Ratio (MRQ)Less than11.348
Return on Equity (MRQ)Greater than0.150.146
Return on Assets (MRQ)Greater than0.050.062
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Kwality Pharmaceuticals Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.159
Ma 20Greater thanMa 50353.213
Ma 50Greater thanMa 100359.048
Ma 100Greater thanMa 200376.468
OpenGreater thanClose353.500
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2017-12-312018-12-312019-12-312020-12-312021-12-31
Other Current Assets  141,29421,203162,497-162,1513469,2759,621-9,622-1
Other Current Liabilities  167,07642,082209,15826,320235,478-235,4762-3-1



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets4,203,525
Total Liabilities2,413,546
Total Stockholder Equity1,789,979
 As reported
Total Liabilities 2,413,546
Total Stockholder Equity+ 1,789,979
Total Assets = 4,203,525

Assets

Total Assets4,203,525
Total Current Assets1,895,063
Long-term Assets1,895,063
Total Current Assets
Cash And Cash Equivalents 27,872
Short-term Investments 4,136
Net Receivables 611,236
Inventory 1,191,051
Total Current Assets  (as reported)1,895,063
Total Current Assets  (calculated)1,834,295
+/- 60,768
Long-term Assets
Property Plant Equipment 2,159,347
Long-term Assets Other 1
Long-term Assets  (as reported)1,127,724
Long-term Assets  (calculated)2,159,348
+/- 1,031,624

Liabilities & Shareholders' Equity

Total Current Liabilities1,464,571
Long-term Liabilities304,967
Total Stockholder Equity1,789,979
Total Current Liabilities
Short-term Debt 1,142,476
Short Long Term Debt 337,230
Accounts payable 345,148
Other Current Liabilities -1
Total Current Liabilities  (as reported)1,464,571
Total Current Liabilities  (calculated)1,824,853
+/- 360,282
Long-term Liabilities
Long term Debt Total 684,502
Long term Debt 683,500
Capital Lease Obligations Min Short Term Debt-1,142,476
Long-term Liabilities Other 1
Long-term Liabilities  (as reported)304,967
Long-term Liabilities  (calculated)225,527
+/- 79,440
Total Stockholder Equity
Common Stock214,668
Retained Earnings 1,496,075
Capital Surplus 79,236
Total Stockholder Equity (as reported)1,789,979
Total Stockholder Equity (calculated)1,789,979
+/-0
Other
Capital Stock103,762
Cash and Short Term Investments 32,008
Common Stock Shares Outstanding 21,467
Liabilities and Stockholders Equity 4,203,525
Net Debt 448,766
Net Invested Capital 2,351,554
Net Working Capital 975,135



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
1,925,916
2,294,950
2,879,051
2,661,938
3,764,898
4,203,525
4,203,5253,764,8982,661,9382,879,0512,294,9501,925,916
   > Total Current Assets 
530,671
749,957
753,538
890,305
1,826,605
1,895,063
1,895,0631,826,605890,305753,538749,957530,671
       Cash And Cash Equivalents 
1,611
1,447
13,983
15,383
37,130
27,872
27,87237,13015,38313,9831,4471,611
       Short-term Investments 
60,762
35,546
62,129
2,374
3,801
4,136
4,1363,8012,37462,12935,54660,762
       Net Receivables 
226,132
370,329
384,276
617,032
555,265
611,236
611,236555,265617,032384,276370,329226,132
       Inventory 
150,230
174,296
152,136
224,168
1,129,483
1,191,051
1,191,0511,129,483224,168152,136174,296150,230
       Other Current Assets 
93,971
141,294
162,497
346
9,621
-1
-19,621346162,497141,29493,971
   > Long-term Assets 
0
0
300,270
436,638
603,644
1,127,724
1,127,724603,644436,638300,27000
       Property Plant Equipment 
170,102
203,795
290,812
426,863
1,871,966
2,159,347
2,159,3471,871,966426,863290,812203,795170,102
       Long-term Assets Other 
0
0
347
2
25
1
125234700
> Total Liabilities 
1,101,850
1,248,870
1,611,648
1,376,258
2,190,280
2,413,546
2,413,5462,190,2801,376,2581,611,6481,248,8701,101,850
   > Total Current Liabilities 
415,955
619,758
608,307
677,525
1,389,227
1,464,571
1,464,5711,389,227677,525608,307619,758415,955
       Short-term Debt 
607,387
552,024
627,021
413,539
879,387
1,142,476
1,142,476879,387413,539627,021552,024607,387
       Short Long Term Debt 
0
0
211,465
247,912
229,641
337,230
337,230229,641247,912211,46500
       Accounts payable 
127,437
221,367
170,679
229,654
262,146
345,148
345,148262,146229,654170,679221,367127,437
       Other Current Liabilities 
126,398
167,076
209,158
235,478
2
-1
-12235,478209,158167,076126,398
   > Long-term Liabilities 
0
0
82,346
199,786
281,224
304,967
304,967281,224199,78682,34600
       Long term Debt Total 
125,416
278,370
583,139
553,844
581,073
684,502
684,502581,073553,844583,139278,370125,416
       Long-term Liabilities Other 
0
0
-1
0
91,804
1
191,8040-100
       Deferred Long Term Liability 
1,038
692
346
0
0
0
0003466921,038
> Total Stockholder Equity
824,066
1,046,080
1,267,403
1,285,680
1,574,618
1,789,979
1,789,9791,574,6181,285,6801,267,4031,046,080824,066
   Common Stock
51,881
103,762
103,762
103,762
143,126
214,668
214,668143,126103,762103,762103,76251,881
   Retained Earnings 
110,462
100,218
175,740
991,776
1,280,714
1,496,075
1,496,0751,280,714991,776175,740100,218110,462
   Capital Surplus 
0
73,563
150,779
150,778
150,778
79,236
79,236150,778150,778150,77973,5630
   Treasury Stock000000
   Other Stockholders Equity 
8,821
8,821
8,821
356,305
0
0
00356,3058,8218,8218,821



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue6,250,734
Cost of Revenue-4,314,828
Gross Profit1,935,9061,935,906
 
Operating Income (+$)
Gross Profit1,935,906
Operating Expense-2,949,327
Operating Income388,520-1,013,421
 
Operating Expense (+$)
Research Development-
Selling General Administrative1,439,774
Selling And Marketing Expenses-
Operating Expense2,949,3271,439,774
 
Net Interest Income (+$)
Interest Income16,400
Interest Expense-30,394
Net Interest Income-29,166-13,994
 
Pretax Income (+$)
Operating Income388,520
Net Interest Income-29,166
Other Non-Operating Income Expenses-
Income Before Tax (EBT)370,671388,520
EBIT - interestExpense = -30,394
261,985
292,379
Interest Expense30,394
Earnings Before Interest and Taxes (ebit)-401,065
Earnings Before Interest and Taxes (ebitda)1,752,969
 
After tax Income (+$)
Income Before Tax370,671
Tax Provision-108,686
Net Income From Continuing Ops1,199,385261,985
Net Income261,985
Net Income Applicable To Common Shares261,985
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-29,166
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
33637L.KO
22 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 33637L.KO.

33637L.KO Daily Candlestick Chart
LOOMIS.ST
36 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of LOOMIS.ST.

LOOMIS.ST Daily Candlestick Chart
KFAST-B.ST
36 minutes ago

I found you a Golden Cross on the daily chart of KFAST-B.ST.

KFAST-B.ST Daily Candlestick Chart
COALA.ST
39 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of COALA.ST.

COALA.ST Daily Candlestick Chart
CFISH.ST
39 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CFISH.ST.

CFISH.ST Daily Candlestick Chart
UIFS.LSE
49 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of UIFS.LSE.

UIFS.LSE Daily Candlestick Chart
RNF.F
54 minutes ago

I found you a RSI Bullish Hidden Divergence on the daily chart of RNF.F.

RNF.F Daily Candlestick Chart
IXX.F
54 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of IXX.F.

IXX.F Daily Candlestick Chart
4AP.F
56 minutes ago

I found you a MACD Bearish Hidden Divergence on the daily chart of 4AP.F.

4AP.F Daily Candlestick Chart
5IC.SG
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 5IC.SG.

5IC.SG Daily Candlestick Chart
INFOMEDIA.BSE
3 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of INFOMEDIA.BSE.

INFOMEDIA.BSE Daily Candlestick Chart
PNAX.TA
3 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of PNAX.TA.

PNAX.TA Daily Candlestick Chart
SHI.VN
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHI.VN.

SHI.VN Daily Candlestick Chart
HLC.VN
3 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of HLC.VN.

HLC.VN Daily Candlestick Chart
VPI.VN
3 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VPI.VN.

VPI.VN Daily Candlestick Chart
CIA.VN
3 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of CIA.VN.

CIA.VN Daily Candlestick Chart
GKM.VN
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of GKM.VN.

GKM.VN Daily Candlestick Chart
TDN.VN
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TDN.VN.

TDN.VN Daily Candlestick Chart
TC6.VN
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TC6.VN.

TC6.VN Daily Candlestick Chart
40N.SG
3 hours ago

I found you a MACD Bullish Reversal Divergence on the daily chart of 40N.SG.

40N.SG Daily Candlestick Chart
HOR.AU
4 hours ago

I found you a Golden Cross on the daily chart of HOR.AU.

HOR.AU Daily Candlestick Chart
IS3.AU
4 hours ago

I found you a RSI Bullish Reversal Divergence on the daily chart of IS3.AU.

IS3.AU Daily Candlestick Chart
CEI.PSE
4 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CEI.PSE.

CEI.PSE Daily Candlestick Chart
COH.AU
4 hours ago

I found you a Golden Cross on the daily chart of COH.AU.

COH.AU Daily Candlestick Chart
CLV.AU
4 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CLV.AU.

CLV.AU Daily Candlestick Chart